Creatine Dosage Guide: Loading, Maintenance, and Timing Protocols

At a Glance

Creatine is the most studied ergogenic supplement in sports medicine and one of the most studied supplements in longevity research. Despite this, clinically actionable dosage specifics are frequently misunderstood or deliberately complicated by marketing. This guide presents what the evidence actually supports.

Loading Phase: Fast-Track to Saturation

Skeletal muscle creatine stores sit near 60–80 % of theoretical maximum in a resting, non-supplemented adult eating a mixed diet. Supplementation raises total creatine (free creatine + phosphocreatine) toward 150–160 mmol/kg dry muscle weight.

The loading approach achieves full saturation in approximately five to seven days:

• 20 g/day divided into four equal doses of 5 g each
• Spread through the day (e.g., with meals and around training)
• Duration: 5–7 days

Why split the dose? Creatine transport is saturated at high single doses. Splitting 20 g into 4 × 5 g doses reduces urinary creatine loss and GI discomfort. A single 20 g bolus causes transient osmotic diarrhoea in a meaningful proportion of people.

The skip-load approach at 3–5 g/day reaches identical saturation but takes approximately three to four weeks. For most longevity-oriented patients — where the endpoint is cognitive and metabolic benefit rather than a competition peaking in two weeks — loading is entirely optional.

Who benefits most from loading?

• Athletes with an event in under two weeks
• Patients initiating creatine for acute sarcopenia risk (hospitalisation, immobility)
• Vegetarians and vegans, who start from a lower baseline and have more room to gain

Maintenance Dosing After Loading

Once stores are saturated, daily turnover of creatine is approximately 1–2 % of total muscle creatine per day, equating to roughly 2–3 g/day that must be replaced. The standard maintenance recommendation therefore sits at 3–5 g/day.

Practical considerations:

• 3 g/day is adequate for a smaller individual (~60 kg) or someone with average dietary creatine intake (omnivore)
• 5 g/day is appropriate for larger individuals (>80 kg), vegetarians, vegans, or older adults (>60 years) where dietary creatine from meat is lower
• 10 g/day has been studied in clinical populations including traumatic brain injury, heart failure, and Parkinson’s disease; no general population benefit beyond 5 g/day has been demonstrated for performance outcomes

There is no compelling evidence to support doses above 5 g/day for longevity or cognitive outcomes in otherwise healthy adults, despite higher doses appearing in some product recommendations.

Timing: Does It Matter?

The post-workout timing hypothesis holds that the anabolic window and insulin-sensitising effect of exercise create a brief period of enhanced creatine uptake. A 2013 randomised trial (Antonio & Ciccone) found statistically greater lean mass gain with post-exercise creatine (~0.3 kg over four weeks). This finding has not been consistently replicated.

Practical guidance:

• If training: take creatine peri-workout (pre or post) for a potential marginal benefit
• If not training that day: timing is irrelevant — take it at any consistent point in the day
• With food: co-ingestion with carbohydrate or protein-carbohydrate blends marginally increases muscle creatine uptake by ~25–30 % via insulin-stimulated transporter upregulation; in practice, taking creatine with a normal meal achieves this

For patients not focused on maximal performance adaptation — including those taking creatine primarily for cognitive, neuroprotective, or bone density benefits — timing has no meaningful clinical relevance. Take it when you remember.

Which Form of Creatine?

This is the area most distorted by marketing.

Creatine monohydrate is the reference compound for every clinical trial demonstrating benefit. Efficacy is established across >500 peer-reviewed studies. Micronised creatine monohydrate dissolves more easily in liquid but is chemically identical.

Creatine HCl (hydrochloride): marketed as requiring a smaller dose (~1.5–2 g) and causing less bloating. The dose equivalence claim has not been validated in comparative studies. No study has demonstrated superior creatine tissue saturation versus monohydrate.

Kre-Alkalyn (buffered creatine): the manufacturing premise — that buffering prevents creatine-to-creatinine conversion in acidic stomach — was shown to be incorrect. Direct comparison studies show no difference in muscle creatine saturation versus monohydrate.

Creatine ethyl ester: inferior to monohydrate in direct comparative studies; actually converts to creatinine at a higher rate.

Verdict: Use creatine monohydrate. The only reason to consider alternatives is true GI intolerance (rare), in which case micronised creatine monohydrate taken with food resolves most cases.

Special Populations: Adjusted Protocols

Older Adults (>60 Years)

Sarcopenia represents the most underappreciated longevity risk. Meta-analyses demonstrate that creatine supplementation combined with resistance training produces approximately 1.4 kg greater lean mass gains than training alone in older adults. This benefit is not reliably seen without training — resistance exercise is the co-intervention.

• Dose: 5 g/day (higher end, to compensate for lower dietary intake)
• Form: monohydrate with a meal
• Pairing: 2–3 × weekly resistance training is required for maximal effect

Vegetarians and Vegans

Dietary creatine comes almost exclusively from animal muscle tissue. Vegetarians have approximately 20 % lower baseline muscle creatine stores. This means:

• Higher relative response to supplementation (more room to fill the tank)
• 5 g/day maintenance is appropriate without prior loading
• Cognitive benefits are more pronounced in this group at baseline

Women

Covered in depth in a dedicated article on creatine for women; key points:

• The same absolute dose (3–5 g/day) is used — no downward adjustment based on body weight is supported by evidence
• Premenstrual and perimenopausal phases appear to show amplified benefit (oestrogen may modulate creatine uptake)
• Safety during pregnancy is not established; discontinue during pregnancy and lactation until more data exist

Athletes in Creatine-Sensitive Sports

For sports with strict weight categories (wrestling, rowing, boxing), the initial ~1–2 kg body weight increase (intramuscular water retention) may be a tactical consideration. This increase is not fat, but shifts the water compartment into muscle tissue. It is fully reversible within two to four weeks of stopping supplementation.

Creatine for Cognitive and Neuroprotective Purposes

The cognitive case for creatine is increasingly well-supported, particularly in populations with reduced dietary intake or elevated neurometabolic demand. The brain maintains its own creatine pool, partially supplied from dietary and supplemental sources.

Evidence supports benefit in:

• Sleep deprivation: 5 g creatine attenuated cognitive decline after 24 hours of sleep deprivation in a double-blind crossover trial
• Vegetarians: significant improvement in memory and processing speed
• Older adults: 5 g/day for 6 months improved memory in a 2022 randomised trial
• Traumatic brain injury: 0.4 g/kg/day (10 g in an 80 kg adult) reduced post-TBI symptoms in a paediatric trial; adult data remain limited

For cognitive indications, the standard 5 g/day dose is used. Higher doses for TBI are a clinical judgement.

Side Effects and Contraindications

Common, manageable:

• GI discomfort with large single doses — resolve by splitting doses; take with food
• Weight increase of 1–2 kg in first two weeks — intramuscular water retention, not fat
• Elevated serum creatinine on standard metabolic panel — creatine is metabolised to creatinine; this is not kidney damage but an artefact that can alarm automated alerts

Contraindications and cautions:

• Established chronic kidney disease (CKD stages 3–5): creatine supplementation is not recommended as the increased creatinine clearance burden may be relevant; discuss with the treating nephrologist
• Kidney disease risk factors without established CKD: no contraindication at 3–5 g/day; monitoring creatinine/eGFR annually is reasonable
• Caffeine at high doses: earlier studies suggested antagonism of creatine’s performance effect; more recent data indicate this is not clinically meaningful at typical caffeine intakes

Not a concern based on current evidence:

• Hair loss: a single 2009 study showed elevated DHT with creatine loading in rugby players; not replicated; mechanistic link to alopecia is speculative
• Liver toxicity: no evidence at standard doses in healthy individuals
• Cycling off: no physiological benefit; stores decline gradually over 4–6 weeks post-cessation

Practical Summary Protocol

Day 1–7 (loading — optional): 20 g/day in 4 × 5 g doses with meals and around training

Day 8 onwards (maintenance): 3–5 g/day, any time, with food

Form: Creatine monohydrate (micronised if preferred for mixability)

Monitoring: No routine monitoring required in healthy individuals; annual renal function in those with risk factors

Related Articles

• Creatine for Longevity: What the Evidence Says
• Creatine and Cognitive Function
• Creatine for Women: Hormonal Considerations and Protocols
• Sarcopenia Prevention: The Physician’s Guide
• Supplement Timing Guide: When to Take What